This section of the website provides information for existing and potential investors in Vectura Group plc including financial reports, an interactive share price chart and updates on our latest news.

Why invest in us?

Vectura's focused application of technology, know-how and expertise has demonstrated that the potential for new inhaled pharmaceuticals with real therapeutic and commercial value can be realised.

Latest performance

Share price chart

Reports and presentations

Annual Report and Accounts for Year Ended 31 March 2014

JP Morgan Healthcare Conference, London

Jefferies 2014 Global Healthcare Conference, New York, 3 June 2014

Latest regulatory news

Share price
Upcoming event
18 Nov 2014

Interim Results for the six months ending 30 September 2014